Daniel C. Brennan, M.D., joins the Johns Hopkins Division of Renal Medicine as professor of nephrology and medical director of the Comprehensive Transplant Center. Dr. Brennan’s areas of clinical expertise include transplant nephrology and renal disease. Prior to joining Johns Hopkins, Dr. Brennan was the Alan A. and Edith L. Wolff Professor of renal Diseases at Washington University and the Director of Transplant Nephrology at the Washington University School of Medicine. He received his undergraduate degree from Cornell College and earned his medical degree at the University of Iowa, where he completed a residency in internal medicine. He then completed research and clinical nephrology fellowships at Brigham & Women’s Hospital/Harvard Medical School. Dr. Brennan holds professional memberships at various organizations, including the American College of Physicians, the International Society of Nephrology, the American Society of Nephrology, The Transplantation Society, the American Society of Transplant Physicians and the American Society of Clinical Investigation. Dr. Brennan is rated as a Distinguished provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Chronic Kidney Disease, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Kidney Transplant, and Pancreas Transplant.

Dr. Sean X. Leng is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include geriatric medicine. Dr. Leng earned his M.D. from Jiangxi Medical College and his Ph.D. from Texas A&M University Health Sciences Center. He completed his residency at Mount Sinai St. Luke's - Roosevelt Hospitals and performed a fellowship in geriatric medicine and gerontology at Johns Hopkins. His research interests include international collaborative development of geriatrics and aging research programs. In 2006 Dr. Leng received the Paul Beeson Career Development Award in Aging Research, one of the most prestigious in the field of geriatric research. Dr. Leng is rated as a Distinguished provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Flu, HIV/AIDS, and Thyroidectomy.

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as an Elite provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is rated as an Advanced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Dr. Fizza Naqvi is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include nephrology, kidney and pancreas transplant. Dr. Naqvi received her medical degree from the Aga Khan Medical College in Karachi, Pakistan. She performed a fellowship in nephrology at the University of Alabama at Birmingham. She completed training in transplant nephrology at Johns Hopkins. Dr. Naqvi speaks English and Urdu. Dr. Naqvi is rated as an Advanced provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, Cytomegalic Inclusion Disease, and Kidney Transplant.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Advanced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

M. Veronica Dioverti, M.D. recently joined as a Clinical Associate in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. She graduated from Universidad Nacional de Asuncion and completed her internship and residency training at Bridgeport Hospital-Yale University in Bridgeport, CT. She then pursued General and Transplant/Oncology Infectious Diseases fellowships at Mayo Clinic in Rochester, MN. Her primary clinical interest is caring for transplant, hematology/oncology malignancies and other immunocompromised patients. Her research has focused on optimizing the diagnosis of cytomegalovirus infection via quantitative nucleic acid testing and risk stratification using Interferon ɣ Release Assays. Other areas of interest include fungal infections in hematologic malignancies. Dr. Prono is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are Meningitis, Cytomegalic Inclusion Disease, Cytomegalovirus Infection, and Parainfluenza.

Dr. Stephen Berry is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV medicine and general infectious diseases. He serves as the Vice Chair for Quality, Safety and Service in the Department of Medicine. Dr. Berry graduated summa cum laude from Emory University and joined the Peace Corps to work as a science teacher in Malawi. He then completed medical school, an internal medicine residency and a chief resident year at the University of Pennsylvania School of Medicine. He performed a fellowship in infectious diseases at Johns Hopkins as well as a Ph.D. from the graduate training program in clinical investigation. Dr. Berry joined the Johns Hopkins faculty in 2010. Dr. Berry’s research focuses on health services utilization and quality and secondary HIV prevention among persons living with HIV. He also focuses on the role of quality metrics in the US healthcare system's transition to value based care. Dr. Berry is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Myelitis, HIV/AIDS, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Olivia Kates is an Infectious Disease provider in Baltimore, Maryland. Dr. Kates is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are COVID-19, Diphtheria, Severe Acute Respiratory Syndrome (SARS), and Listeriosis.

Dr. C. John Sperati is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Sperati is Director of the Glomerular Diseases Fellowship Program since 2023 and formerly directed the Nephrology Fellowship Training Program from 2019 - 2025. He was the long-serving Firm Faculty Leader of the Barker Firm and has held leadership positions within the Osler Medical Residency training program. In addition, he co-directs the Johns Hopkins Osler Learning Initiative which brings the principles of medical residency training to executive education worldwide. He obtained his medical degree from The Pennsylvania State University College of Medicine and a Master in Health Science from the Johns Hopkins Bloomberg School of Public Health. He completed an internship and residency in Internal Medicine at the Johns Hopkins Hospital, followed by a year as an Assistant Chief of Service (chief resident). He subsequently pursued subspecialty training in nephrology at the Johns Hopkins Hospital and joined the faculty in the Division of Nephrology. Dr. Sperati’s clinical interests are in thrombotic microangiopathy including atypical hemolytic uremic syndrome (aHUS), complement-mediated kidney diseases including C3 glomerulopathy, glomerular disease such as glomerulonephritis (e.g., IgA nephropathy, MPGN) and nephrotic syndromes (e.g., FSGS, membranous, minimal change, amyloidosis, and others), and secondary and resistant hypertension (e.g., fibromuscular dysplasia, atherosclerotic renal arterial disease, hyperaldosteronism, and genetic hypertensive syndromes). He is the site principal investigator for clinical trials in glomerular disease, serves on editorial boards, and chairs the approval committee of the Longitudinal Knowledge Assessment for nephrology for the American Board of Internal Medicine. His clinical acumen and educational contributions have been recognized by induction into the Miller Coulson Academy of Clinical Excellence as well as the American Society of Nephrology Distinguished Educator Award in 2020. He has been recognized as a physician resource through the Atypical HUS Foundation, a NephCure glomerular disease specialist, an IgA Nephropathy Foundation specialist, and a Baltimore TopDoc. He is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sperati is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Glomerulonephritis, and Kidney Transplant.

Kapil Saharia is an Infectious Disease provider in Baltimore, Maryland. Dr. Saharia is rated as a Distinguished provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Myelitis, and HIV/AIDS.

Stuart C. Ray, MD, FACP, FIDSA is a Professor in the Division of Infectious Diseases within the Department of Medicine, with a research appointment in Oncology. He is a virologist and clinical investigator in the Viral Immunity & Pathogenesis Center in the Division of Infectious Diseases. He is a faculty member of the Janeway Firm of the Osler Medical Service, and the graduate programs in Immunology, Pharmacology, and Health Sciences Informatics. He is a member of the Johns Hopkins Medicine AI & Data Trust Council, and Co-Chair of the Research Data Subcouncil. Dr. Ray received his M.D. from Vanderbilt University School of Medicine in 1990. After an internship and residency at Johns Hopkins Hospital, he continued there as an Assistant Chief of Service and fellow in Infectious Diseases. During his fellowship, he studied the immunology and sequence variation of HIV in the laboratory of Dr. Robert Bollinger. During that time, he developed an interest in RNA virus evolution in productive collaborations with Dr. Robert Siliciano. In 1997 Dr. Ray joined the Johns Hopkins faculty, and under the mentorship of Dr. David Thomas shifted his primary research focus to hepatitis C virus (HCV). His laboratory work has focused on the evolution of HCV during acute and chronic infection, developing and applying computational and molecular biology tools to underlying mechanisms including stochastic variation, immune selection, and viral fitness. He continues to care for patients with HIV, HCV, and other infectious diseases. Dr. Ray is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Severe Acute Respiratory Syndrome (SARS).

Dr. Nate Permpalung is an Associate Professor of Medicine and serves as the Director of Mycology Research in the Division of Infectious Diseases and Associate Director for Clinical Trials of Transplant Research Center at Johns Hopkins University School of Medicine. In his capacity as a Transplant Infectious Disease physician at Johns Hopkins Hospital, he provides specialized care to immunocompromised patients, including those who have undergone solid organ transplants and those undergoing cancer treatment. His research focuses are respiratory viral infections, invasive fungal infections, fungal-viral interactions, fungal diagnostics, and human pythiosis. Nationally, Dr. Permpalung has served on the panel for the IDSA Aspergillosis Guidelines development and has held editorial positions as Associate Editor for Medical Mycology and as an Editorial Board Member for the Journal of Heart and Lung Transplantation Open. Dr. Permpalung is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Febrile Neutropenia, Parainfluenza, Pneumocystis Jiroveci Pneumonia, and COVID-19.

Dr. Rabb attended medical school at McGill University in Montreal and graduated as University Scholar. After internship and residency in Internal Medicine at the UCLA School of Medicine, Harbor-UCLA Medical Center, he completed a clinical nephrology fellowship at the Massachusetts General Hospital and Harvard Medical School. This was followed in the same institutions by basic research training in leukocyte biology/immunology. Dr. Rabb is currently Professor in the Departments of Medicine and Surgery, and Medical Director of the Johns Hopkins Kidney Transplant Program. He has been elected to the American Society of Clinical Investigation and American Association of Professors. Dr. Rabb is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Cerebral Hypoxia, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Glomerulonephritis, and Kidney Transplant.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Nada Alachkar is an associate professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include incompatible kidney transplants, kidney transplants, nephrology and pancreas transplants. Dr. Alachkar earned her M.D. at Aleppo University Faculty of Medicine in Syria. She completed residencies at Aleppo University and Wright State University School of Medicine. She performed clinical fellowship in nephrology and transplant nephrology fellowship at Johns Hopkins University. Her research interests include recurrent glomerular diseases post kidney transplantation; in particular recurrent FSGS post transplant. Also, she is studying biomarkers in kidney transplants; outcome of living and deceased donor kidney transplant recipients with positive crossmatch; and responses to desensitization treatments and post-transplant outcome in highly sensitized patients. Dr. Alachkar is a member of the American Society of Nephrology and the American Society of Transplantation. Dr. Alachkar is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are Focal Segmental Glomerulosclerosis, Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Kidney Transplant, and Splenectomy.

Dr. Edward Kraus is a Professor of Medicine in the Department of Medicine, Division of Nephrology, at the Johns Hopkins University School of Medicine. He completed his undergraduate education at Cornell University, received his MD at Northwestern University and completed an Internal Medicine residency at Cleveland Metropolitan General Hospital in Cleveland, OH. After completing a Nephrology Fellowship at Baltimore City Hospitals, Dr. Kraus has been a member of the faculty since 1981. As part of his clinical duties he has cared for kidney transplant patients during his entire tenure at Johns Hopkins. As the scope of the kidney transplant program grew, his clinical responsibilities during the last 15 years have been limited to care of kidney and pancreas transplant donors and recipients. He currently serves as the Senior Kidney Transplant Nephrologist and Medical Director of the Pancreas Transplant Program. Dr. Kraus’ interests have focused upon factors affecting the long-term outcomes of kidney transplant recipients and barriers to access of care for minority recipients. He has worked extensively with Pathology and has participated in the development of the Johns Hopkins Incompatible Kidney Transplant Program with particular emphasis on evolving concepts of patterns of injury with the goal of development of clinical interventions to preserve allograft function. Dr. Kraus is a member of the National Kidney Foundation, the American Society of Nephrology, the International Society of Nephrology and the American Society of Transplantation. He actively serves on Committees of these various organizations. Upon nomination by his patients, students and peers in recognition for his clinical care and teaching skills, Dr. Kraus was inducted into the Miller-Coulson Academy of Clinical Excellence at the Johns Hopkins Bayview Medical Center. Dr. Kraus is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Cytomegalic Inclusion Disease, Kidney Transplant, and Splenectomy.

Anju Yadav is a Nephrologist and a Transplant Surgeon in Baltimore, Maryland. Dr. Yadav is rated as an Advanced provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD).

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis.

William F. Wright, D.O., M.P.H, Assistant Professor of Medicine, completed medical training residency in internal medicine and adult infectious diseases fellowship at Pennylvania State University Medical School. He pursued further training in Clinical Pathology/Medical Microbiology at Yale University School of Medicine, New Haven (2009) and completed his Master in Public Health (2007) at Drexel University School of Public Health, Philadelphia. His research interests include fever of unknown origin (FUO), antimicrobial resistance and therapeutic discoveries, molecular mechanisms of resistance, and the impact of diagnostic clinical microbiology on the practice of infectious diseases. He currently serves as clinical director for the inpatient infectious diseases consult services and services for the management of outpatient parenteral antimicrobial therapy (OPAT) at Johns Hopkins Bayview Medical Center. His outpatient clinical practice focuses on general infectious diseases, infections in burn patients, infections in immunocompromised patients, and travel-related infections. He primarily sees patients at Johns Hopkins Greenspring Station, Johns Hopkins Bayview Outpatient offices, and also attends on the inpatient infectious disease consult service at the Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. Dr. Wright is rated as an Experienced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Meningitis, and Endocarditis.